Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

REVEALED: Cowen co org - The Real Truth

Benzinga's Top Ratings Upgrades, Downgrades For November 3, 2022

Meta Platforms To $200? These Analysts Slash Price Targets On Meta Following Q3 Results

Meta Platforms To $200? These Analysts Slash Price Targets On Meta Following Q3 Results

Meta Platforms, Inc. (NASDAQ: META) reported worse-than-expected Q3 EPS and issued Q4 revenue guidance with a midpoint below estimates. The company also guided FY23 expenses of $96 billion to $101 billion. Meta Platforms shares dropped 22.1% to $101.20 on Thursday.

Alphabet To $145? These Analysts Cut Price Targets On Alphabet After Downbeat Q3 Results

Alphabet To $145? These Analysts Cut Price Targets On Alphabet After Downbeat Q3 Results

Alphabet Inc. (NASDAQ: GOOGL) reported weaker-than-expected earnings results for its third quarter after the closing bell on Tuesday.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Benzinga's Top Ratings Upgrades, Downgrades For October 18, 2022

This Is What Whales Are Betting On Lululemon Athletica

Someone with a lot of money to spend has taken a bullish stance on Lululemon Athletica (NASDAQ:LULU). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga's Top Ratings Upgrades, Downgrades For September 22, 2022

Why Nuwellis Surged Over 121%; Here Are 66 Biggest Movers From Yesterday

inkl

Read news from The Economist, FT, and more,
with one subscription

Why Express Is Trading Higher By Over 21%, Here Are 54 Stocks Moving In Wednesday's Mid-Day Session

Why Express Is Trading Higher By Over 21%, Here Are 54 Stocks Moving In Wednesday's Mid-Day Session

Gainers Nuwellis, Inc. (NASDAQ: NUWE) shares jumped 140% to $1.5894 after the company announced new clinical data demonstrating 100% survival at 30 days following the use of ultrafiltration in high-risk postoperative coronary artery bypass grafting patients.

Benzinga's Top Ratings Upgrades, Downgrades For August 31, 2022

Benzinga's Top Ratings Upgrades, Downgrades For August 31, 2022

Salesforce Faces Price Target Cuts On Guidance Cut, Shares Slide

Salesforce Faces Price Target Cuts On Guidance Cut, Shares Slide

Salesforce Inc (NYSE: CRM) reported upbeat results for its second quarter, but lowered its annual projections.

Benzinga's Top Ratings Upgrades, Downgrades For August 2, 2022

Benzinga's Top Ratings Upgrades, Downgrades For August 2, 2022

Benzinga's Top Ratings Upgrades, Downgrades For July 8, 2022

Benzinga's Top Ratings Upgrades, Downgrades For July 8, 2022

Pioneers In The Cannabis Industry: Meet Senior Analyst Vivien Azer At Benzinga's Cannabis Capital Conference In Chicago

Pioneers In The Cannabis Industry: Meet Senior Analyst Vivien Azer At Benzinga's Cannabis Capital Conference In Chicago

In times of regulatory uncertainty, inflation and stock market volatility, defining an investment strategy can be a wicked problem. Estimating the future of how cannabis stocks can profit from market trends requires experience, a holistic perspective, good information and an extensive network of personal relationships in the industry.

Benzinga's Top Ratings Upgrades, Downgrades For June 24, 2022

Benzinga's Top Ratings Upgrades, Downgrades For June 24, 2022

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga's Top Ratings Upgrades, Downgrades For May 25, 2022

Upgrades Credit Suisse upgraded the previous rating for Molecular Partners AG (NASDAQ:MOLN) from Underperform to Neutral. NoneAt the moment, the stock has a 52-week-high of $32.04 and a 52-week-low of $5.92. Molecular Partners closed at $6.88 at the end of the last trading period.

Benzinga's Top Ratings Upgrades, Downgrades For May 23, 2022

Benzinga's Top Ratings Upgrades, Downgrades For May 13, 2022

Amazon.com Whale Trades Spotted

Someone with a lot of money to spend has taken a bearish stance on Amazon.com (NASDAQ:AMZN). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga's Top Ratings Upgrades, Downgrades For May 4, 2022

1

People

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

Amazon.com Inc.

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play